Silo Pharma raises $4M in private placement; warrants could add $7.7M

Silo Pharma, Inc.

Issued 619,965 shares (or pre-funded warrants) at $6.452/share plus Series A-3 and A-4 warrants.
Warrants exercisable at $6.21/share; Series A-3 expire 5 years, Series A-4 expire 18 months after registration.
Net proceeds expected ~$3.5M after fees; H.C. Wainwright acted as placement agent.
Proceeds to be used for working capital and general corporate purposes.
Potential additional $7.7M if all warrants exercised for cash; no assurance of exercise.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.